EUCTR2011-002175-42-AT进行中（未招募）不适用
The effect and safety of dexmedetomidine as an additive to ropivacaine for interscalene brachial plexus blocks for shoulder surgery
Paracelsus Medizinische Universität - Universitätsklinik für Anästhesie0 个研究点开始时间: 2011年9月5日最近更新:
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •ASA I-III adult subjects
- •Elective shoulder surgery
- •Plan for interscalene brachial plexus block combined with general anesthesia
- •Interscalene block placed between 7:00 a.m. and 12:00 a.m.
- •Willingness to be contacted postoperatively for brief (5-10 min) phone call
- •questionnaires
- •Written informed consent
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 62
- •F.1.3 Elderly (>=65 years) no
- •F.1.3.1 Number of subjects for this age range
排除标准
- •Age < 18
- •Age > 65
- •Inability to understand protocol due to language barrier
- •Coagulation/bleeding disorders
- •Chronic pain requiring daily opioids > 15 mg oral morphine equivalents (equals oral
- •usage of > 10 mg oxycodone/daily; > 5 mg methadone/day; > 4 mg hydromorphone/day)
- •Moderate (NRS pain score > 3) daily average pain
- •Daily use of gabapentin, pregabalin, tricyclic antidepressant, serotonin-norepinephrine
- •reuptake inhibitor, tramadol, corticosteroids
- •Hypersensitivity to amide local anesthetics
- •History of hypersensitivity or allergic reaction to clonidine or dexmedetomidine
- •Oxycodone allergy (oxycodone to be used for postoperative pain)
- •Uncontrolled anxiety
- •Schizophrenia or bipolar disorder
- •Preexisting nerve damage (sensory or motor) in the extremity to be blocked
- •Peripheral neuropathy
- •Significant respiratory disease (chronic obstructive pulmonary disease or asthma
- •requiring daily therapy)
- •Significant cardiovascular disease (second or third degree heart block, congestive heart
- •failure, symptomatic coronary artery disease)
- •BMI > 35
- •Uncontrolled diabetes (blood sugar > 250 recorded in last month)
- •Chronic clonidine therapy (clonidine patch – Catapres or clonidine tablets)
- •Hepatic Impairment
- •Renal Impairment
- •Ongoing drug or alcohol abuse
- •Local cutaneous infection at site of nerve block placement
- •Hearing impairment
- •Pregnancy
- •Prisoners
研究者
相似试验
已完成
4 期
The effect of adding dexmedetomidine to bupivacaine in paravertebral block.nerve Block.adverse of therapeutic useIRCT2015121212642N23Vice chancellor for research, Iran University of Medical Sciences42
招募中
3 期
The effect of Dexmedetomidine on myocardial protection in patients undergoing Mitral valve replacement/ repairEvaluation of the effect of adding dexmedetomidine to del-Nido cardioplegia solution on myocardial protection in patients undergoing mitral valve replacement / repair.Nonrheumatic mitral valve disordersIRCT20210713051881N1Mashhad University of Medical Sciences56
尚未招募
Unknown
Efficacy and Safety of use of Dexmedetomidine for Hypotensive Anaesthesia in Patients undergoing Functional Endoscopic sinus surgeryCTRI/2024/07/070582Dr Sridevi Mulimani
已完成
早期 1 期
Dexmedetomidine in success of nerve blockPulpitisasymptomatic irreversible pulpitis.IRCT20150815023620N8Tehran Azad University, Dentistry Faculty50
已完成
2 期
The evaluation of the effect of dexmedetomidine added to local infiltration of bupivacaine on post-operative pain of pediatric inguinal herniorraphy.Inguinal herniaInguinal hernia.IRCT2016060314372N8Vice Chancellor for Research, Shiraz University of Medical Sciences60